Pharmaxis provides FDA resubmission for Aridol US marketing application

27th Apr 10

Release Date: 27/04/2010 12:00am

Pharmaxis today announced that the U.S. Food and Drug Administration has acknowledged receipt of the resubmission of its New Drug Application for Aridol™ (mannitol inhalation powder).

 

Read full media release - pdf

Categories: News and Media